Women with a BRCA1 mutation face a significantly increased lifetime risk of breast cancer, with estimates ranging from 60% to 72%, while those with a BRCA2 mutation have a high lifetime risk of 55% to 77% [37]. This evidence concerns the gene BRCA2 and breast cancer.